New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
1
32

Rheumatoid Arthritis Diet & Treatment. Information resource | Patient

Rheumatoid arthritis (RA) is a chronic systemic disease. Early diagnosis of RA and effective treatment with disease-modifying anti-rheumatic drugs. Find out arthritis diets rheumatoid arthritis treatment.  
Patient.co.uk
over 5 years ago
Preview
1
26

Psoriatic Arthritis. What is psoriatric arthritis? Information | Patient

Synonyms: psoriatic arthropathy, arthropathia psoriatica, arthritis mutilans, seronegative arthritis associated with psoriasis See also separate articles...  
Patient.co.uk
over 5 years ago
Preview
1
23

Gout | Doctor | Patient

Gout can be defined as arthritis due to deposition of monosodium urate (MSU) monohydrate crystals within joints causing acute inflammation and eventual...  
Patient.co.uk
over 5 years ago
Preview
1
26

Calcium Pyrophosphate Deposition - including Pseudogout | Doctor | Patient

Pseudogout is an inflammation of joints caused by the deposition of calcium pyrophosphate (CPP) crystals in articular and periarticular tissues. It is...  
Patient.co.uk
over 5 years ago
Preview
1
34

Reactive Arthritis. Information about Reactive Arthritis | Patient

Reactive Arthritis is also known as Reiter's syndrome. Reactive arthritis is an autoimmune condition that develops in response to an infection.  
Patient.co.uk
over 5 years ago
Preview
1
42

Juvenile Idiopathic Arthritis. JIA information | Patient

Juvenile Idiopathic Arthritis can be known as Still's disease, juvenile arthritis, juvenile chronic arthritis, juvenile rheumatoid arthritis. More about Juvenile Idiopathic Arthritis (JIA)  
Patient.co.uk
over 5 years ago
Www.bmj
1
40

Drug treatments for rheumatoid arthritis: looking backwards to move forwards

Over the past 40 years the clinical picture has improved for patients with rheumatoid arthritis thanks to key steps in drug development and care strategy. These steps include the introduction of methotrexate in 1980 and the first inhibitors of tumour necrosis factor (TNF) in 2000. This was followed by the development of new biotechnology products to target other cytokines, cell subsets, and cell interaction pathways. All these products are expensive drugs with obvious consequences for health systems with limited resources.  
bmj.com
over 5 years ago
Www.bmj
1
11

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 5 years ago
Www.bmj
1
17

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 5 years ago
Www.bmj
1
3

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 5 years ago
Www.bmj
1
7

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
over 5 years ago
Www.bmj
1
13

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 5 years ago
Www.bmj
1
10

Drug treatments for rheumatoid arthritis: looking backwards to move forwards

Over the past 40 years the clinical picture has improved for patients with rheumatoid arthritis thanks to key steps in drug development and care strategy. These steps include the introduction of methotrexate in 1980 and the first inhibitors of tumour necrosis factor (TNF) in 2000. This was followed by the development of new biotechnology products to target other cytokines, cell subsets, and cell interaction pathways. All these products are expensive drugs with obvious consequences for health systems with limited resources.  
bmj.com
over 5 years ago
Www.bmj
1
11

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Objective To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.  
bmj.com
over 5 years ago
Preview
1
31

Gout. It is always gout! | EMBlog Mayo Clinic

Author: Tim Bongartz, MD. Scenario: A 54 year old male is presenting to the ED with severe right foot and ankle pain and swelling. The …  
emblog.mayo.edu
about 5 years ago
Preview
1
62

The foot and ankle in rheumatology | Arthritis Research UK

Philip Helliwell, Heidi Siddle, Anthony Redmond Foot and Ankle Studies in Rheumatology Group, Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds  
arthritisresearchuk.org
about 5 years ago
Preview
1
8

Arthritis-India

Pain at multiple body areas is a common problem affecting 7-13% of western population. Most studies indicate a female preponderance and association with psychological distress in these cases. Pain is usually present for many years. Generalised pain needs to be distinguished from various forms of arthritis. Pain in these conditions does not have exact localization and usually not restricted to joints. Patients may complain of pain in other areas such as bones, muscles and back. Although severity of chronic generalised or widespread pain can vary from one individual to another it does affect physical functions and emotions leading to diminished quality of life. Chronic widespread pain can occur in children too. These conditions have direct societal impact in addition to direct and indirect medical costs.Causes of Generalised PainVarious conditions can cause generalised pain. Some of these are listed below:  
arthritis-india.com
about 5 years ago
Preview
1
19

Acute Polyarthritis type of arthritis. Acute Polyarthritis info. Patient | Patient

Acute polyarthritis has differential diagnosis & diagnostic difficulties. With acute polyarthritis oligoarthritis joints sometimes affected. Read about Acute Polyarthritis  
patient.co.uk
about 5 years ago
Preview
1
5

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other synthetic disease modifying drugs.  
bmj.com
almost 5 years ago
8
1
14

ten-things-you-need-to-know-about-arthritis-31441158.html

Arthritis is an inflammation of the joints which causes pain and immobility ranging from mild to severe, and, even though it affects 10 million people in the UK, we don't have a cure fo  
belfasttelegraph.co.uk
almost 5 years ago